Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers
ABSTRACT Objective The goal of this study was to determine the prevalence of SARS‐CoV‐2 infections in pediatric front‐line health care workers (HCWs) using SARS‐CoV‐2 serum antibodies as an indicator of infection. Methods In this cross‐sectional study, we collected blood samples and survey responses...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | Journal of the American College of Emergency Physicians Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/emp2.12743 |
_version_ | 1811238021206376448 |
---|---|
author | Hannah Wilkins Ebaa Jastaniah Beverly Spray James C. Forrest Karl W. Boehme Catherine Kirkpatrick Bobby L. Boyanton Jr. David M. Spiro Lee Crawley Lawrence Quang Joshua L. Kennedy |
author_facet | Hannah Wilkins Ebaa Jastaniah Beverly Spray James C. Forrest Karl W. Boehme Catherine Kirkpatrick Bobby L. Boyanton Jr. David M. Spiro Lee Crawley Lawrence Quang Joshua L. Kennedy |
author_sort | Hannah Wilkins |
collection | DOAJ |
description | ABSTRACT Objective The goal of this study was to determine the prevalence of SARS‐CoV‐2 infections in pediatric front‐line health care workers (HCWs) using SARS‐CoV‐2 serum antibodies as an indicator of infection. Methods In this cross‐sectional study, we collected blood samples and survey responses from HCWs in a 38‐bed pediatric emergency department. Serum antibodies to SARS‐CoV‐2 (IgM and/or IgG) were measured using a 2‐step enzyme‐linked immunosorbent assay (ELISA) to detect antibodies against the Spike protein receptor binding domain (RBD), the ectodomain of Spike (S), and the nucleoprotein (N). Results We collected survey responses and serum samples from 54 pediatric front‐line HCWs from October 2020 through April 2021. Among the 29 unvaccinated HCWs, 4 (13.7%) had antibodies to SARS‐CoV‐2. For the 25 vaccinated HCWs, 10 (40%) were seropositive; 3 were <10 days from the first vaccine dose and 7 were ≥10 days after the first dose. Two of the 10 seropositive vaccines had a prior positive reverse transcription polymerase chain reaction test. Individuals ≥10 days from receiving the first vaccine dose were 37.5 (95% CI: 3.5–399.3) times more likely to have SARS‐CoV‐2 antibodies than unvaccinated individuals or those <10 days from first vaccine dose. Conclusions Evidence of widespread SARS‐CoV‐2 infections was not found in unvaccinated front‐line HCWs from a pediatric ED as of April 2021. Future work will be required to determine the reasons underlying the lower SARS‐CoV‐2 antibody prevalence compared to adult HCWs. |
first_indexed | 2024-04-12T12:33:25Z |
format | Article |
id | doaj.art-bfab170342d94717a264fd7ee1b068b9 |
institution | Directory Open Access Journal |
issn | 2688-1152 |
language | English |
last_indexed | 2024-04-12T12:33:25Z |
publishDate | 2022-06-01 |
publisher | Wiley |
record_format | Article |
series | Journal of the American College of Emergency Physicians Open |
spelling | doaj.art-bfab170342d94717a264fd7ee1b068b92022-12-22T03:32:57ZengWileyJournal of the American College of Emergency Physicians Open2688-11522022-06-0133n/an/a10.1002/emp2.12743Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workersHannah Wilkins0Ebaa Jastaniah1Beverly Spray2James C. Forrest3Karl W. Boehme4Catherine Kirkpatrick5Bobby L. Boyanton Jr.6David M. Spiro7Lee Crawley8Lawrence Quang9Joshua L. Kennedy10Department of Pediatrics Division of Pediatric Emergency Medicine College of Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USADepartment of Pediatrics Division of Pediatric Emergency Medicine College of Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USAArkansas Children's Research Institute Little Rock Arkansas USADepartment of Microbiology & Immunology College of Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USADepartment of Microbiology & Immunology College of Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USAArkansas Children's Research Institute Little Rock Arkansas USADepartment of Pathology and Laboratory Medicine College of Medicine University of Arkansas for Medical Sciences Little Rock AR USADepartment of Pediatrics Division of Pediatric Emergency Medicine College of Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USAArkansas Children's Research Institute Little Rock Arkansas USADepartment of Pediatrics Division of Pediatric Emergency Medicine College of Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USAArkansas Children's Research Institute Little Rock Arkansas USAABSTRACT Objective The goal of this study was to determine the prevalence of SARS‐CoV‐2 infections in pediatric front‐line health care workers (HCWs) using SARS‐CoV‐2 serum antibodies as an indicator of infection. Methods In this cross‐sectional study, we collected blood samples and survey responses from HCWs in a 38‐bed pediatric emergency department. Serum antibodies to SARS‐CoV‐2 (IgM and/or IgG) were measured using a 2‐step enzyme‐linked immunosorbent assay (ELISA) to detect antibodies against the Spike protein receptor binding domain (RBD), the ectodomain of Spike (S), and the nucleoprotein (N). Results We collected survey responses and serum samples from 54 pediatric front‐line HCWs from October 2020 through April 2021. Among the 29 unvaccinated HCWs, 4 (13.7%) had antibodies to SARS‐CoV‐2. For the 25 vaccinated HCWs, 10 (40%) were seropositive; 3 were <10 days from the first vaccine dose and 7 were ≥10 days after the first dose. Two of the 10 seropositive vaccines had a prior positive reverse transcription polymerase chain reaction test. Individuals ≥10 days from receiving the first vaccine dose were 37.5 (95% CI: 3.5–399.3) times more likely to have SARS‐CoV‐2 antibodies than unvaccinated individuals or those <10 days from first vaccine dose. Conclusions Evidence of widespread SARS‐CoV‐2 infections was not found in unvaccinated front‐line HCWs from a pediatric ED as of April 2021. Future work will be required to determine the reasons underlying the lower SARS‐CoV‐2 antibody prevalence compared to adult HCWs.https://doi.org/10.1002/emp2.12743COVIDCOVID‐19healthcare workerspediatric emergency departmentSARS‐CoV‐2 antibodiesvaccine response |
spellingShingle | Hannah Wilkins Ebaa Jastaniah Beverly Spray James C. Forrest Karl W. Boehme Catherine Kirkpatrick Bobby L. Boyanton Jr. David M. Spiro Lee Crawley Lawrence Quang Joshua L. Kennedy Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers Journal of the American College of Emergency Physicians Open COVID COVID‐19 healthcare workers pediatric emergency department SARS‐CoV‐2 antibodies vaccine response |
title | Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers |
title_full | Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers |
title_fullStr | Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers |
title_full_unstemmed | Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers |
title_short | Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers |
title_sort | seroprevalence of sars cov 2 antibodies in front line pediatric health care workers |
topic | COVID COVID‐19 healthcare workers pediatric emergency department SARS‐CoV‐2 antibodies vaccine response |
url | https://doi.org/10.1002/emp2.12743 |
work_keys_str_mv | AT hannahwilkins seroprevalenceofsarscov2antibodiesinfrontlinepediatrichealthcareworkers AT ebaajastaniah seroprevalenceofsarscov2antibodiesinfrontlinepediatrichealthcareworkers AT beverlyspray seroprevalenceofsarscov2antibodiesinfrontlinepediatrichealthcareworkers AT jamescforrest seroprevalenceofsarscov2antibodiesinfrontlinepediatrichealthcareworkers AT karlwboehme seroprevalenceofsarscov2antibodiesinfrontlinepediatrichealthcareworkers AT catherinekirkpatrick seroprevalenceofsarscov2antibodiesinfrontlinepediatrichealthcareworkers AT bobbylboyantonjr seroprevalenceofsarscov2antibodiesinfrontlinepediatrichealthcareworkers AT davidmspiro seroprevalenceofsarscov2antibodiesinfrontlinepediatrichealthcareworkers AT leecrawley seroprevalenceofsarscov2antibodiesinfrontlinepediatrichealthcareworkers AT lawrencequang seroprevalenceofsarscov2antibodiesinfrontlinepediatrichealthcareworkers AT joshualkennedy seroprevalenceofsarscov2antibodiesinfrontlinepediatrichealthcareworkers |